PuSH - Publication Server of Helmholtz Zentrum München

141 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Hess, J. et al.: A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV-infection. Clin. Cancer Res. 25, 1505-1516 (2019)
2.
Hess, J. et al.: A five-microRNA-signature predicts recurrence and survival in HPV-negative HNSCC. Strahlenther. Onkol. 195, S25-S25 (2019)
3.
Klymenko, O. et al.: Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding genomic copy number alterations and radiation response. Strahlenther. Onkol. 195, S75-S76 (2019)
4.
Liu, X.* et al.: Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. Sci. Adv. 5:eaav4275 (2019)
5.
Osterode, E.* et al.: Evaluation of CD44v6 targeting strategies in HNSCC. Strahlenther. Onkol. 195, S176-S176 (2019)
6.
Piehlmaier, D. et al.: In-vitro and in-vivo characterization of a glioblastoma cell line panel. Strahlenther. Onkol. 195, S63-S64 (2019)
7.
Schnoeller, L.* et al.: In-depth characterization of radiation response in a human glioblastoma cell line panel. Strahlenther. Onkol. 195, S120-S121 (2019)
8.
Schötz, U. et al.: Inherent resistance of head and neck tumors: Cellular senescence and associated cyokine production as key mechanisms in vitro and in vivo. Strahlenther. Onkol. 195, S76-S76 (2019)
9.
Unger, K. et al.: Validation of a 4-miRNA prognosticator allowing for improved risk stratification of glioblastoma patients in combination with MGMT promoter methylation status. Strahlenther. Onkol. 195, S63-S63 (2019)
10.
Wintergerst, L. et al.: A 16q24.3 4-gene mRNA signature predicts outcome in radio(chemo)therapy-treated head and neck squamous cell carcinoma. Strahlenther. Onkol. 195, S24-S25 (2019)
11.
Baumeister, P. et al.: High expression of EpCAM and Sox2 is a positive prognosticator of clinical outcome for head and neck carcinoma. Sci. Rep. 8:14582 (2018)
12.
Caldwell, R.B. ; Braselmann, H. ; Heuer, S. ; Schötz, U.* & Zitzelsberger, H.: Gain-of-function analysis of cis-acting diversification elements in DT40 cells. Immunol. Cell Biol. 96, 948-957 (2018)
13.
Chumak, V.V.* et al.: Doses of Ukrainian female clean-up workers with diagnosed breast cancer. Radiat. Environ. Biophys. 57, 163–168 (2018)
14.
Dalke, C. et al.: Lifetime study in mice after acute low-dose ionizing radiation: A multifactorial study with special focus on cataract risk. Radiat. Environ. Biophys. 57, 99-113 (2018)
15.
Klymenko, O. et al.: HNSCC derived cell lines and subclones differ in genomic copy number changes and radiation response. Radiother. Oncol. 127, S1266-S1267 (2018)
16.
Maihoefer, C. et al.: Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat. Oncol. 13:123 (2018)
17.
Schoetz, U.* et al.: Prognostic biomarkers and targets for personalization of radiotherapy of HNSCC: CD44v6. Radiother. Oncol. 127, S251-S251 (2018)
18.
Wilke, C. et al.: Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer. Int. J. Cancer 142, 573-583 (2018)
19.
Wilke, C. et al.: A genomic copy number signature predicts radiation exposure in post-Chernobyl breast cancer. Int. J. Cancer 143, 1505-1515 (2018)
20.
Wintergerst, L. et al.: A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Mol. Oncol., accepted (2018)